August 1st 2025
Review some of the top stories from the Contemporary OB/GYN website over the past week and catch up on anything you may have missed.
FDA panel recommends HPV DNA test as first-line cervical cancer screening
March 20th 2014In a unanimous vote, a Food and Drug Administration (FDA) advisory committee has recommended that the agency give premarket approval to a human papillomavirus (HPV) DNA test as first-line screening for cervical cancer.
Read More
Pelvic organ prolapse surgeries have similar outcomes
March 20th 2014According to a recent study in JAMA, neither the sacrospinous ligament fixation (SSLF) nor the uterosacral ligament vaginal vault suspension (ULS) procedure is superior to the other in the treatment of vaginal prolapse and stress urinary incontinence.
Read More
Oophorectomy cuts risk of cancer in BRCA1/2 carriers
March 6th 2014A study by Canadian researchers shows that preventive oophorectomy reduces risk of ovarian, fallopian tube, or peritoneal cancer by 80% in women who have BRCA1 or BRCA2 mutations. Published in The Journal of Clinical Oncology, the report also documented a 77% reduction in all-cause mortality.
Read More
Postmenopausal genital tract tuberculosis in the United States: A report of two cases
March 1st 2014When a postmenopausal patient presents with signs and symptoms of a gynecologic malignancy, one should consider the possibility of genital tuberculosis in women who have immigrated to the United States.
Read More
Power morcellation for uterine fibroids: What you need to know
March 1st 2014Gynecologic surgeons should give consideration to the balance of benefit and harm that accompanies laparoscopic tissue morcellation, in addition to exploring surgical alternatives and methods to mitigate complications.
Read More
Some institutions and groups defining stances on morcellation
March 1st 2014Some societies and institutions are developing formal policies on morcellation in response to an increase in public concern over the possibility of this procedure spreading and upstaging undetected cancer in the uterus.
Read More
HRT may lower risk of repeat knee/hip replacement
January 30th 2014Taking hormone replacement therapy (HRT) for at least 6 months after total knee arthroplasty (TKA) or total hip arthroplasty (THA) may reduce risk of repeat surgery. So say the results of a community-based cohort study of women in the UK who had undergone TKA or THA for osteoarthritis.
Read More
Minimally Invasive Surgery: New Devices of Interest
January 14th 2014The latest devices and gadgetry for minimally invasive gynecological surgery were featured in the exhibit hall at the 42nd AAGL Global Congress on Minimally Invasive Gynecology held just outside of Washington, DC, November 10-14, 2013.
Read More